Shustik, Chaim <br/><br/>
A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7.  [electronic resource] 

 -  British journal of haematology  Jan 2007 
 - 203-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1048 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2006.06405.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Prednisone--administration & dosage<br/>Proportional Hazards Models<br/>Remission Induction<br/>Survival Rate<br/>Treatment Outcome